Top Markets
#1 TENDIES TENDIES +42.62%
#2 Cash Cat Cash Cat +27.92%
#3 ICON ICON +23.59%
#4 Asteroid Shiba Asteroid Shiba +17.29%
#5 OSK OSK +15.36%
#6 MarsCoin MarsCoin +13.78%
#7 Threshold Network Threshold Network +12.29%
#8 龙虾 (Lobster) 龙虾 (Lobster) +10.00%
#9 Tornado Cash Tornado Cash +9.69%
#10 Kite Kite +9.57%
Coin of the day
TENDIES TENDIES
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
Classificação em ações #16882
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Preço da ação
$2.52
Valor de mercado
$274.65M
Variação (1 dia)
0.46%
Variação (1 ano)
-56.11%
País
CN
Negociar VISEN Pharmaceuticals (2561)

Categoria

Healthcare
Lucros da VISEN Pharmaceuticals (2561)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da VISEN Pharmaceuticals, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da VISEN Pharmaceuticals de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH